Generation of two iPSC lines (MHHi001-A-12 and MHHi001-A-13) carrying biallelic truncating mutations at the 3'-end of SRCAP using CRISPR/Cas9

Stem Cell Res. 2023 Dec:73:103249. doi: 10.1016/j.scr.2023.103249. Epub 2023 Nov 16.

Abstract

Non-Floating Harbour Syndrome (FLHS) neurodevelopmental disorder (NDD) is a recently described disorder caused by mutations in certain regions of the SRCAP gene. We generated two iPSC lines that contain truncating mutation on both alleles at the 3'-end of SRCAP using CRISPR/Cas9 technology. Both cell lines are pluripotent, differentiate into the 3 germ layers and contain no genomic aberrations or off-target modifications. The cell lines form part of a human disease model to investigate the effects of truncating mutations in different regions of SRCAP.

MeSH terms

  • Adenosine Triphosphatases / genetics
  • Adenosine Triphosphatases / metabolism
  • CRISPR-Cas Systems* / genetics
  • Cell Line
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Mutation / genetics

Substances

  • compound A 12
  • SRCAP protein, human
  • Adenosine Triphosphatases